HomeSHTPY • OTCMKTS
add
Schott Pharma Unsponsored ADR
Previous close
$4.50
Year range
$4.50 - $7.65
Market cap
3.25B EUR
Avg Volume
7.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 256.46M | 1.13% |
Operating expense | 35.98M | 10.22% |
Net income | 45.56M | -1.51% |
Net profit margin | 17.77 | -2.58% |
Earnings per share | 0.30 | -3.23% |
EBITDA | 79.85M | 12.55% |
Effective tax rate | 23.96% | — |
Balance Sheet
Total assets
Total liabilities
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 28.29M | 27.69% |
Total assets | 1.53B | 9.23% |
Total liabilities | 663.12M | 5.30% |
Total equity | 865.03M | — |
Shares outstanding | 151.88M | — |
Price to book | 0.79 | — |
Return on assets | 9.97% | — |
Return on capital | 13.15% | — |
Cash Flow
Net change in cash
| (EUR) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 45.56M | -1.51% |
Cash from operations | 55.18M | -4.73% |
Cash from investing | -37.89M | -56.48% |
Cash from financing | -14.41M | 52.04% |
Net change in cash | 2.20M | -29.99% |
Free cash flow | -28.83M | -170.61% |
About
Schott Pharma is a provider of drug containment solutions and delivery systems for injectable drugs. Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023. Headquartered in Mainz, Germany, the company operates in 14 countries. Wikipedia
Founded
Aug 1, 2022
Website
Employees
4,775
